Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART ...

Funding to fight HIV among gay and bisexual men and transgender women is a fraction of what it should be, researchers said on Tuesday, with advocates blaming stigma for the shortfall.

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

High stigma levels correlate with lower ART adherence and viral suppression in women with HIV, especially those who inject drugs. The study used data from the WIHS, focusing on stigma's impact on HIV ...

A University of Massachusetts public health researcher has received four grants totaling $17.9 million from the National Institutes of Health to launch three projects that will build on existing ...

SPOKANE, Wash. – The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the approval, Dr. Rachel Safran was part of an original ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New ...

Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and afford them, experts have said. Taken as directed, modern medications can ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...

People living with HIV and Aids will now have increased access to treatment and prevention medicines after the Supreme Court of Appeal ruled against an association representing a small group of ...